Literature DB >> 8298709

Appearance of IgE antibodies to ingested and inhaled allergens during the first 12 years of life in atopic and non-atopic children.

G Hattevig1, B Kjellman, B Björkstén.   

Abstract

The appearance and course of serum immunoglobulin E-antibodies (IgE-ab) to egg-white (EW), cow's milk (CM) and inhalants (pollen, danders and mite) were followed from birth to 12 years of age in 84 children unselected for family history of atopy. During the follow-up 36 children developed atopic symptoms and 48 children did not. IgE-ab to EW and CM reached a peak prevalence at 8 months of age--with high concentrations almost exclusively in atopics and disappeared successively during childhood. IgE-ab to inhalants appeared from 2 years of age and then in increasing frequency during childhood. Similar to the pattern of IgE-ab to EW and CM, transient low levels of IgE-ab to inhalants were commonly encountered in non-atopic children while high concentrations without tendency to decline were almost exclusively seen in atopics. High responders to EW-antigen during infancy were usually also high responders to inhalants during childhood. Clinical allergy to EW and CM and subsequent tolerance appeared early in childhood, whereas allergy to inhalants appeared later and did not disappear. The temporary low-grade IgE antibody response in non-atopic individuals to eaten and inhaled allergens is similar to the results of animal studies demonstrating a transient IgE production followed by tolerance.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8298709     DOI: 10.1111/j.1399-3038.1993.tb00089.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  17 in total

Review 1.  Immune mechanisms of childhood asthma.

Authors:  C E Donovan; P W Finn
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

2.  Random allergen-specific IgE expression in atopic families: evidence for inherited "stochastic bias" in adverse immune response development to non-infectious antigens.

Authors:  Duaine R Jackola
Journal:  Mol Immunol       Date:  2007-01-23       Impact factor: 4.407

Review 3.  Regulation of IgE production and other immunopathogenetic mechanisms.

Authors:  B A Chowdhury
Journal:  Clin Rev Allergy Immunol       Date:  1995       Impact factor: 8.667

Review 4.  Polyunsaturated n-3 fatty acids and the development of atopic disease.

Authors:  K Duchén; B Björkstén
Journal:  Lipids       Date:  2001-09       Impact factor: 1.880

5.  Progressive polarization towards a T helper/cytotoxic type-1 cytokine pattern during age-dependent maturation of the immune response inversely correlates with CD30 cell expression and serum concentration.

Authors:  M Krampera; F Vinante; L Tavecchia; L Morosato; M Chilosi; S Romagnani; M E Zanolin; G Pizzolo
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

6.  Season of birth as predictor of atopic manifestations.

Authors:  L Nilsson; B Björkstén; G Hattevig; B Kjellman; N Sigurs; N I Kjellman
Journal:  Arch Dis Child       Date:  1997-04       Impact factor: 3.791

7.  Sensitization to food and inhalant allergens in relation to age and wheeze among children with atopic dermatitis.

Authors:  J A Wisniewski; R Agrawal; S Minnicozzi; W Xin; J Patrie; P W Heymann; L Workman; T A Platts-Mills; T W Song; M Moloney; J A Woodfolk
Journal:  Clin Exp Allergy       Date:  2013-10       Impact factor: 5.018

8.  Introduction of various allergenic foods during infancy reduces risk of IgE sensitization at 12 months of age: a birth cohort study.

Authors:  Man-Chin Hua; Tsung-Chieh Yao; Chien-Chang Chen; Ming-Han Tsai; Sui-Ling Liao; Shen-Hao Lai; Chih-Yung Chiu; Kuan-Wen Su; Kuo-Wei Yeh; Jing-Long Huang
Journal:  Pediatr Res       Date:  2017-08-09       Impact factor: 3.756

9.  Family structure, neonatal infection, and hay fever in adolescence.

Authors:  D P Strachan; E M Taylor; R G Carpenter
Journal:  Arch Dis Child       Date:  1996-05       Impact factor: 3.791

Review 10.  Allergy prevention. Interventions during pregnancy and early infancy.

Authors:  Bengt Björkstén
Journal:  Clin Rev Allergy Immunol       Date:  2004-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.